These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1531976

  • 1. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
    Wallen CA, Moore SK, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
    [Abstract] [Full Text] [Related]

  • 2. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
    Wong KH, Wallen CA, Wheeler KT.
    J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513
    [Abstract] [Full Text] [Related]

  • 3. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
    Wong KH, Zhang H, Wallen CA, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1992 Aug; 23(4):831-9. PubMed ID: 1618675
    [Abstract] [Full Text] [Related]

  • 4. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH, Wallen CA, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW, Allalunis-Turner MJ.
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [Abstract] [Full Text] [Related]

  • 6. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH, Urano M.
    Int J Radiat Oncol Biol Phys; 1992 Oct; 23(3):593-8. PubMed ID: 1612960
    [Abstract] [Full Text] [Related]

  • 8. Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
    Hirst DG, Hazlehurst JL, Brown JM.
    Br J Cancer; 1984 Jan; 49(1):33-42. PubMed ID: 6229264
    [Abstract] [Full Text] [Related]

  • 9. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 10. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
    Wong KH, Wallen CA, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
    [Abstract] [Full Text] [Related]

  • 11. The effect of timing on chemosensitization by clinical levels of SR-2508.
    Hirst DG, Horsman MR, Brown JM, Hazlehurst JL.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1641-5. PubMed ID: 6237082
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 13. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
    Hinchliffe M, McNally NJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
    [Abstract] [Full Text] [Related]

  • 15. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA, Siemann DW.
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors.
    Clement JJ, Johnson RK.
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(3-4):631-4. PubMed ID: 7107387
    [Abstract] [Full Text] [Related]

  • 17. Effect of thiol manipulation on chemopotentiation by nitroimidazoles.
    Siemann DW, Flaherty AA, Penney DP.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1341-5. PubMed ID: 2715088
    [Abstract] [Full Text] [Related]

  • 18. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L, Ito H, Hunter N.
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [Abstract] [Full Text] [Related]

  • 19. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM, Dionet C, Brown JM.
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.